Metastatic Bladder Urothelial Carcinoma Clinical Trials in Chicago, Illinois

Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors